During the past decade, University of Miyazaki Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 4 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Miyazaki Hospital" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Celgene" with 2 trials sponsored, "Incyte Corporation" with 2 trials sponsored and "Japan Rhabdomyosarcoma Study Group" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Miyazaki Hospital" #1 collaborator was "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "Medtronic Japan Co., Ltd." with 1 trials as a collaborator and "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "University of Miyazaki Hospital" are "Myelofibrosis" (4 trials), "Primary Myelofibrosis" (4 trials), "Prostatic Neoplasms" (3 trials), "Diabetic Macular Edema" (2 trials) and "Post Essential Thrombocythemia Myelofibrosis" (2 trials). Many other conditions were trialed in "University of Miyazaki Hospital" in a lesser frequency.

Most popular intervention types in "University of Miyazaki Hospital" are "Drug" (23 trials), "Other" (5 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Faricimab" (4 trials), "Sham Procedure" (4 trials), "placebo" (3 trials) and "Aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Miyazaki Hospital" are 22 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "University of Miyazaki Hospital". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University of Miyazaki Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Miyazaki Hospital, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".